Search results
Found 7019 matches for
Oxford University doctors and scientists are performing the second phase of clinical studies of an experimental Ebola vaccine regimen. The study is part of the EBOVAC2 project, a collaborative programme involving the University of Oxford, French Institute of Health and Medical Research (INSERM) as project coordinator, London School of Hygiene & Tropical Medicine, Le Centre Muraz, Inserm Transfert (IT) and the Janssen Pharmaceutical Companies of Johnson & Johnson.
Amber Thompson
Amber Thompson - Senior QA and Sample Compliance Manager
Sarah Kelly
MSc Sarah Kelly - Clinical Programme Director (Global)
Sir Andrew Pollard
BSc MBBS PhD (Lond), DIC, MRCP (UK), FHEA, FRCPCH, MA, FMedSci, FRS Sir Andrew Pollard - Ashall Professor of Infection & Immunity
Yama G.Farooq
BCA Computer Application , MSc in Information Technology and Software Engineering Yama G.Farooq - Programming and Data Management Director
James Gilchrist
MBioch, MBBS, MRCPCH, DPhil, PGDip Paediatric Infectious Diseases James Gilchrist - Wellcome Career Development Fellow